missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ TMEM184C Polyclonal Antibody
Description
A suggested positive control is mouse heart tissue lysate. PA5-20933 can be used with blocking peptide PEP-1047.
Anaplastic thyroid cancer is one of the most lethal forms of cancer, but the precise carcinogenic mechanism has not been identified. TMEM184C, also known as TMEM34, was identified in a cDNA microarray analysis as being down-regulated in anaplastic thyroid cancers compared to normal thyroid tissues. TMEM184C protein expression was also lower in cell lines derived from these types of cancers compared to that of normal thyroid tissues or cell lines based on other types of thyroid cancers. Furthermore, transfection of TMEM34 into KTA2 cells led to the inhibition of cell growth, suggesting that TMEM184C might act as a tumor suppressor in anaplastic thyroid cancers.
Specifications
Specifications
| Antigen | TMEM184C |
| Applications | Immunohistochemistry, Western Blot |
| Classification | Polyclonal |
| Concentration | 1 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 0.02% sodium azide |
| Gene | TMEM184C |
| Gene Accession No. | Q3TPR7, Q810F5, Q9NVA4 |
| Gene Alias | 8430433H16Rik; AI645453; AL033298; BC004056; DNA sequence AY228474; PRO1355; TMEM184C; Tmem34; Transmembrane protein 184C; transmembrane protein 34 |
| Gene Symbols | TMEM184C |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?